Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
BGO Ventures was founded to tackle challenges in health technology, emerging from the expertise of BGO Software in the sector. Established in Baltimore, Maryland, the firm also operates offices in London, United Kingdom, and Sofia, Bulgaria. BGO Ventures collaborates with venture builders and founders to support healthcare startups, focusing on transforming proven ideas into market-ready solutions.
The firm emphasizes enhancing the healthcare landscape through innovation, particularly in areas such as artificial intelligence, digital therapeutics, and clinical trials. BGO Ventures has a clear mission to provide not only capital but also operational support, leveraging the engineering capabilities of BGO Software to help startups navigate the complexities of the healthcare industry.
As of now, BGO Ventures has not disclosed specific fund sizes or portfolio counts, but it actively engages with healthcare startups to drive impactful innovations. The firm’s commitment to addressing health technology challenges positions it as a significant player in the venture capital space.
BGO Ventures invests primarily in healthcare innovations, with a strong emphasis on artificial intelligence, digital therapeutics, and clinical trials. The firm targets startups at the Seed, Series A, and Series B funding stages, providing capital and hands-on support to help them navigate the complexities of the healthcare industry. Their investment strategy focuses on optimizing manufacturing workflows and enhancing clinical trial processes through regulatory knowledge and data expertise.
In addition to financial backing, BGO Ventures offers operational support, drawing on the engineering capabilities of BGO Software. This support is crucial for startups looking to scale effectively in a challenging regulatory environment. The firm seeks to partner with founders who are addressing significant challenges in health technology, particularly those that can leverage AI and machine learning to improve healthcare outcomes.
BGO Ventures has invested in several notable companies within the healthcare sector. Their portfolio includes:
These companies reflect BGO Ventures' commitment to supporting innovations that address significant challenges in health technology, particularly through the application of AI and data-driven solutions.
Ivailo Ivanov - CTO of BGO Software, brings extensive experience in technology and engineering, focusing on health tech solutions.
Ivan Lekushev - CEO & Co-founder of BGO Software, has a strong background in business development and strategic partnerships within the healthcare sector.
Todor Todorov - Investment Manager, specializes in identifying and evaluating investment opportunities in healthcare startups.
Daniela Tsoneva - Investment Manager, focuses on supporting portfolio companies and enhancing their operational capabilities.
Advisory Board members include Bert-Arjan Millenaar, Sava Kobilarov, Mira Ganova, Evelina Georgieva, and Pierre-Mikael Legris, who provide strategic guidance and industry insights.
To pitch BGO Ventures, founders should email hello@bgoventures.com with a detailed pitch deck. The deck should include information about the startup's mission, market opportunity, and how it plans to address challenges in the healthcare sector. BGO Ventures appreciates clear and concise presentations that highlight the startup's unique value proposition.
Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are preferred, as they can facilitate a more favorable review process.
As of April 2023, BGO Ventures has been actively engaging with healthcare startups, focusing on transforming proven ideas into market-ready solutions. The firm continues to support innovations that address challenges in health technology, leveraging its experience from BGO Software.
Recent portfolio highlights include investments in companies like Ansana, HEMEO, and SoCyber, which reflect BGO Ventures' commitment to enhancing the healthcare landscape through technology and innovation.
What are BGO Ventures' investment criteria?
BGO Ventures focuses on healthcare innovations, particularly in artificial intelligence, digital therapeutics, and clinical trials. They invest at the Seed, Series A, and Series B stages, looking for startups that can navigate the complexities of the healthcare industry.
How can I pitch to BGO Ventures?
Founders can reach out to BGO Ventures via email at hello@bgoventures.com. It is advisable to include a detailed pitch deck that outlines the startup's vision, market opportunity, and how it addresses specific challenges in healthcare.
What makes BGO Ventures different from other investors?
BGO Ventures not only provides capital but also offers hands-on operational support, leveraging the engineering capabilities of BGO Software. This unique approach helps startups optimize their processes and navigate regulatory challenges effectively.
What geographic areas does BGO Ventures focus on?
The firm primarily invests in North America and Europe, with offices located in Baltimore, London, and Sofia. This geographic focus allows them to tap into diverse healthcare markets and innovations.
What is the typical check size for investments?
While specific check sizes are not disclosed, BGO Ventures invests at the Seed, Series A, and Series B stages, which typically involve varying amounts of capital depending on the startup's needs and growth stage.
What kind of post-investment support does BGO Ventures provide?
BGO Ventures offers operational support and guidance to portfolio companies, helping them navigate the complexities of the healthcare industry. This includes assistance with regulatory navigation and optimizing clinical trial processes.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.